Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Credit agrmnt [a]
Appointed director
Inv. presentation
Quarterly results
Acq. announced
Director departure
|
|
Bausch Health Companies Inc. (BHC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/07/2023 |
4/A
| Carson Seana (EVP, General Counsel) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Sold 780 shares
@ $9.34, valued at
$7.3k
Sold 495 shares
@ $9.17, valued at
$4.5k
|
|
| 10/03/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/03/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/06/2022 |
4/A
| ROBERTSON RUSSEL C (Director) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Granted 4,314 shares
@ $8.36, valued at
$36.1k
|
|
| 02/28/2020 |
4/A
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Exercised 7,864 options to buy
@ $0 |
|
| 09/18/2018 |
4/A
| APPIO THOMAS (Pres&Co-Head Bausch&Lomb/Int'l) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 6,604 shares
@ $21.69, valued at
$143.2k
|
|
| 05/08/2018 |
4/A
| Hale David Robert (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| WECHSLER AMY B (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| Ross Thomas W. Sr. (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| ROBERTSON RUSSEL C (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| POWER ROBERT N (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| Paulson John (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| KAVANAGH SARAH B (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| KARABELAS ARGERIS N (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/08/2018 |
4/A
| DE SCHUTTER RICHARD U (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 01/29/2018 |
4/A
| APPIO THOMAS (EVP, COMPANY GROUP CHAIRMAN) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 1,264 shares
@ $23.85, valued at
$30.1k
|
|
| 12/20/2016 |
4/A
| Whitaker Anne Clem (EVP, Company Group Chairman) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
| 05/10/2016 |
4/A
| Morfit G Mason (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
| 05/28/2013 |
4/A
| POWER ROBERT N (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
| 01/04/2013 |
4/A
| MELAS KYRIAZI THEO (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
| 01/04/2013 |
4/A
| MELAS KYRIAZI THEO (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
| 10/04/2012 |
4/A
| Chai-Onn Robert Roswell (EVP, Gen. Couns. & Corp. Sec.) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
| 10/27/2011 |
4/A
| Masterson Richard Kevin (Pres. & COO, Valeant Int. (BB)) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
| 08/24/2011 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 04/11/2011 |
4/A
| Loberg Philip Walden Jr (EVP, Interim CFO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 694 shares
@ $0 |
|
| 04/11/2011 |
4/A
| Provencio Norma Ann (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Bought 1,000 shares
@ $39.87, valued at
$39.9k
Bought 195 shares
@ $39.88, valued at
$7.8k
Bought 380 shares
@ $39.88, valued at
$15.2k
|
|
| 04/11/2011 |
4/A
| Provencio Norma Ann (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Bought 1,000 shares
@ $24.75, valued at
$24.8k
Bought 4,000 shares
@ $24.75, valued at
$99k
|
|
| 04/11/2011 |
4/A
| Provencio Norma Ann (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 98,930 shares
@ $0
Granted 9,051 shares
@ $0
Granted 28,795 shares
@ $0
Granted 6,233 shares
@ $0 |
|
| 04/11/2011 |
4/A
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Sold 9,872 shares
@ $40, valued at
$394.9k
|
|
| 04/11/2011 |
4/A
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 7,275 shares
@ $0 |
|
| 04/11/2011 |
4/A
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 210,449 shares
@ $0
Granted 9,872 shares
@ $0 |
|
| 04/11/2011 |
4/A
| MELAS KYRIAZI THEO (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 5,869 shares
@ $0 |
|
| 04/08/2011 |
4/A
| MELAS KYRIAZI THEO (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 169,316 shares
@ $0
Granted 26,713 shares
@ $0 |
|
| 04/07/2011 |
4/A
| ValueAct Holdings, L.P. (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc. |
|
|
|